Histone deacetylase inhibitors: The anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)
Nataly Tarasenko, Abraham Nudelman, Igor Tarasenko, Michal Entin-Meer, Daphne Hass-Kogan, Aida Inbal, Ada Rephaeli*
Research output: Contribution to journal › Article › peer-review
35Scopus
citations
Fingerprint
Dive into the research topics of 'Histone deacetylase inhibitors: The anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)'. Together they form a unique fingerprint.